CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso to Acquire Psychedelics Company, Halucenex, page-24

  1. 914 Posts.
    lightbulb Created with Sketch. 394
    I disagree, I think it's an excellent strategic move which, if we can get regulatory approval - will allow CPH to break in to a huge new market that most other ASX cannabis stocks currently do not have access to.

    Viewing this opportunity as a "new illegal drug business pathway" is the rigid, 1970s type of mindset that had cannabis blacklisted as a gateway drug to begin with. This opportunity broadens our addressable market considerably. Alternative therapies for mental health, PTSD should not be underestimated as a potential market.

    We're on track for record sales this year and aggressively establishing supply agreements and partnerships, however I do see the concern regarding high rate of cash burn. At the end of the day it's up to the individual SH to determine whether or not they want to invest long term or not, but that's where the money is going to be. Long termers will be rewarded IMHO.

 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.